name,category,termsATP-binding cassette, sub-family F (GCN20), member 1,COG_ONTOLOGY[90000073$General function prediction only]
ATP-binding cassette, sub-family F (GCN20), member 1,INTERPRO[450003006$IPR003439:ABC transporter-like, 450003154$IPR003593:ATPase, AAA+ type, core, 450016190$IPR017871:ABC transporter, conserved site]
ATP-binding cassette, sub-family F (GCN20), member 1,SMART[760000335$SM00382:AAA]
ATP-binding cassette, sub-family F (GCN20), member 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000138$atp-binding, 790000356$complete proteome, 790000811$isopeptide bond, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001592$ubl conjugation]
ATP-binding cassette, sub-family F (GCN20), member 1,UP_SEQ_FEATURE[850006558$chain:ATP-binding cassette sub-family F member 1, 850102507$compositionally biased region:Glu-rich, 850102720$cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), 850102998$domain:ABC transporter 1, 850102999$domain:ABC transporter 2, 850106258$modified residue, 850106264$nucleotide phosphate-binding region:ATP 1, 850106265$nucleotide phosphate-binding region:ATP 2, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
CDC42 small effector 2,INTERPRO[450000079$IPR000095:PAK-box/P21-Rho-binding]
CDC42 small effector 2,SMART[760000256$SM00285:PBD]
CDC42 small effector 2,SP_PIR_KEYWORDS[790000264$cell membrane, 790000268$cell shape, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000881$lipoprotein, 790000919$membrane, 790001100$palmitate, 790001136$phagocytosis]
CDC42 small effector 2,UP_SEQ_FEATURE[850010191$chain:CDC42 small effector protein 2, 850102566$compositionally biased region:Poly-Arg, 850103411$domain:CRIB, 850105898$lipid moiety-binding region:S-palmitoyl cysteine]
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, assembly factor 3,INTERPRO[450006877$IPR007523:Protein of unknown function DUF498]
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, assembly factor 3,SP_PIR_KEYWORDS[790000356$complete proteome, 790000446$disease mutation, 790000919$membrane, 790000969$mitochondrion, 790000970$mitochondrion inner membrane, 790001065$nucleus]
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, assembly factor 3,UP_SEQ_FEATURE[850033514$chain:NADH dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 3, 850117295$sequence variant]
NDRG family member 4,INTERPRO[450003654$IPR004142:Ndr]
NDRG family member 4,PIR_SUPERFAMILY[630019009$PIRSF023830:Caenorhabditis elegans hypothetical protein ZK1073.1]
NDRG family member 4,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000428$developmental protein, 790001162$phosphoprotein]
NDRG family member 4,UP_SEQ_FEATURE[850047002$chain:Protein NDRG4, 850102582$compositionally biased region:Poly-Thr, 850106258$modified residue, 850118574$splice variant]
SRY (sex determining region Y)-box 9,INTERPRO[450000793$IPR000910:High mobility group, HMG1/HMG2]
SRY (sex determining region Y)-box 9,OMIM_DISEASE[520000092$Acampomelic campomelic dysplasia, 520000736$Campomelic dysplasia, 520000737$Campomelic dysplasia with autosomal sex reversal]
SRY (sex determining region Y)-box 9,SMART[760000349$SM00398:HMG]
SRY (sex determining region Y)-box 9,SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790000446$disease mutation, 790000466$dna-binding, 790001065$nucleus, 790001539$Transcription, 790001543$transcription regulation]
SRY (sex determining region Y)-box 9,UP_SEQ_FEATURE[850065337$chain:Transcription factor SOX-9, 850102501$compositionally biased region:Gln/Pro-rich, 850102580$compositionally biased region:Poly-Pro, 850102920$DNA-binding region:HMG box, 850105852$helix, 850117295$sequence variant, 850118575$strand]
WD repeat domain 31,INTERPRO[450001490$IPR001680:WD40 repeat, 450014355$IPR015943:WD40/YVTN repeat-like, 450016294$IPR017986:WD40 repeat, region, 450018010$IPR019775:WD40 repeat, conserved site, 450018016$IPR019781:WD40 repeat, subgroup, 450018017$IPR019782:WD40 repeat 2]
WD repeat domain 31,SMART[760000289$SM00320:WD40]
WD repeat domain 31,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001212$polymorphism, 790001304$repeat, 790001638$wd repeat]
WD repeat domain 31,UP_SEQ_FEATURE[850100736$chain:WD repeat-containing protein 31, 850117171$repeat:WD 1, 850117182$repeat:WD 2, 850117193$repeat:WD 3, 850117195$repeat:WD 4, 850117196$repeat:WD 5, 850117295$sequence variant, 850118574$splice variant]
activating signal cointegrator 1 complex subunit 1,INTERPRO[450003602$IPR004087:K Homology, 450003603$IPR004088:K Homology, type 1, 450008322$IPR009210:Predicted eukaryotic LigT, 450016411$IPR018111:K Homology, type 1, subgroup]
activating signal cointegrator 1 complex subunit 1,PIR_SUPERFAMILY[630020619$PIRSF027019:Euk_LigT, 630020620$PIRSF027019:phosphoesterase, eukaryotic LigT type]
activating signal cointegrator 1 complex subunit 1,SMART[760000291$SM00322:KH]
activating signal cointegrator 1 complex subunit 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790001212$polymorphism, 790001539$Transcription, 790001543$transcription regulation]
activating signal cointegrator 1 complex subunit 1,UP_SEQ_FEATURE[850003662$chain:Activating signal cointegrator 1 complex subunit 1, 850104520$domain:KH, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
adducin 1 (alpha),BIOCARTA[30000223$h_PDZsPathway:Synaptic Proteins at the Synaptic Junction]
adducin 1 (alpha),INTERPRO[450001148$IPR001303:Class II aldolase/adducin, N-terminal]
adducin 1 (alpha),OMIM_DISEASE[520002478$Hypertension, essential, salt-sensitive]
adducin 1 (alpha),SP_PIR_KEYWORDS[790000012$acetylation, 790000019$actin-binding, 790000053$alternative splicing, 790000218$calmodulin-binding, 790000264$cell membrane, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000445$direct protein sequencing, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism]
adducin 1 (alpha),UP_SEQ_FEATURE[850004690$chain:Alpha-adducin, 850106258$modified residue, 850106259$mutagenesis site, 850112141$region of interest:Interaction with calmodulin, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3A,INTERPRO[450007252$IPR007904:APOBEC-like, C-terminal, 450011795$IPR013158:APOBEC-like, N-terminal, 450014525$IPR016192:APOBEC/CMP deaminase, zinc-binding]
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3A,SP_PIR_KEYWORDS[790000356$complete proteome, 790000445$direct protein sequencing, 790000743$hydrolase, 790000937$metal-binding, 790001212$polymorphism, 790001648$zinc]
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3A,UP_SEQ_FEATURE[850000131$active site:Proton donor, 850041736$chain:Probable DNA dC->dU-editing enzyme APOBEC-3A, 850106244$metal ion-binding site:Zinc; catalytic, 850117295$sequence variant]
chromosome 19 open reading frame 12,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000919$membrane, 790001555$transmembrane]
chromosome 19 open reading frame 12,UP_SEQ_FEATURE[850073499$chain:Uncharacterized protein C19orf12, 850118574$splice variant, 850118623$transmembrane region]
cleft lip and palate associated transmembrane protein 1,INTERPRO[450007706$IPR008429:Cleft lip and palate transmembrane 1]
cleft lip and palate associated transmembrane protein 1,OMIM_DISEASE[520002966$Lung cancer susceptibility locus at 5p15.33]
cleft lip and palate associated transmembrane protein 1,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000316$chromosomal rearrangement, 790000356$complete proteome, 790000428$developmental protein, 790000434$differentiation, 790000616$glycoprotein, 790000919$membrane, 790001162$phosphoprotein, 790001555$transmembrane]
cleft lip and palate associated transmembrane protein 1,UP_SEQ_FEATURE[850011684$chain:Cleft lip and palate transmembrane protein 1, 850105770$glycosylation site:N-linked (GlcNAc...), 850106258$modified residue, 850117294$sequence conflict, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
collagen, type VI, alpha 2,INTERPRO[450001802$IPR002035:von Willebrand factor, type A, 450007490$IPR008160:Collagen triple helix repeat]
collagen, type VI, alpha 2,KEGG_PATHWAY[470038853$hsa04510:Focal adhesion, 470038854$hsa04512:ECM-receptor interaction]
collagen, type VI, alpha 2,OMIM_DISEASE[520000561$Bethlem myopathy, 520003529$Myosclerosis, congenital, 520004976$Ullrich congenital muscular dystrophy]
collagen, type VI, alpha 2,PIR_SUPERFAMILY[630002388$PIRSF002259:collagen VI]
collagen, type VI, alpha 2,SMART[760000296$SM00327:VWA]
collagen, type VI, alpha 2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000189$blocked amino end, 790000256$cell adhesion, 790000257$cell binding, 790000344$coiled coil, 790000345$collagen, 790000356$complete proteome, 790000445$direct protein sequencing, 790000446$disease mutation, 790000530$extracellular matrix, 790000616$glycoprotein, 790000745$hydroxylation, 790000746$hydroxylysine, 790000747$hydroxyproline, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001289$pyroglutamic acid, 790001304$repeat, 790001363$Secreted, 790001405$signal, 790001565$trimer, 790001568$triple helix]
collagen, type VI, alpha 2,UP_SEQ_FEATURE[850012207$chain:Collagen alpha-2(VI) chain, 850105628$domain:VWFA 1, 850105633$domain:VWFA 2, 850105634$domain:VWFA 3, 850105770$glycosylation site:N-linked (GlcNAc...), 850106258$modified residue, 850113761$region of interest:Nonhelical region, 850114937$region of interest:Triple-helical region, 850117294$sequence conflict, 850117295$sequence variant, 850117335$short sequence motif:Cell attachment site, 850117814$signal peptide, 850118574$splice variant]
family with sequence similarity 19 (chemokine (C-C motif)-like), member A5,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000919$membrane, 790001363$Secreted, 790001555$transmembrane]
family with sequence similarity 19 (chemokine (C-C motif)-like), member A5,UP_SEQ_FEATURE[850045946$chain:Protein FAM19A5, 850118574$splice variant, 850118623$transmembrane region]
filamin C, gamma (actin binding protein 280),INTERPRO[450001143$IPR001298:Filamin/ABP280 repeat, 450001411$IPR001589:Actinin-type, actin-binding, conserved site, 450001520$IPR001715:Calponin-like actin-binding, 450012396$IPR013783:Immunoglobulin-like fold, 450016187$IPR017868:Filamin/ABP280 repeat-like]
filamin C, gamma (actin binding protein 280),KEGG_PATHWAY[470038827$hsa04010:MAPK signaling pathway, 470038853$hsa04510:Focal adhesion]
filamin C, gamma (actin binding protein 280),OMIM_DISEASE[520003504$Myopathy, myofibrillar, filamin C-related]
filamin C, gamma (actin binding protein 280),SMART[760000025$SM00033:CH, 760000496$SM00557:IG_FLMN]
filamin C, gamma (actin binding protein 280),SP_PIR_KEYWORDS[790000002$3d-structure, 790000017$actin binding, 790000019$actin-binding, 790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000445$direct protein sequencing, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat]
filamin C, gamma (actin binding protein 280),UP_SEQ_FEATURE[850019488$chain:Filamin-C, 850103007$domain:Actin-binding, 850103318$domain:CH 1, 850103319$domain:CH 2, 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850111881$region of interest:Hinge 1, 850111882$region of interest:Hinge 2, 850112444$region of interest:Interaction with INPPL1, 850113138$region of interest:Intradomain insert, 850114627$region of interest:Self-association site, tail, 850115955$repeat:Filamin 1, 850115956$repeat:Filamin 10, 850115957$repeat:Filamin 11, 850115958$repeat:Filamin 12, 850115959$repeat:Filamin 13, 850115960$repeat:Filamin 14, 850115961$repeat:Filamin 15, 850115962$repeat:Filamin 16, 850115963$repeat:Filamin 17, 850115964$repeat:Filamin 18, 850115965$repeat:Filamin 19, 850115966$repeat:Filamin 2, 850115967$repeat:Filamin 20, 850115968$repeat:Filamin 21, 850115969$repeat:Filamin 22, 850115970$repeat:Filamin 23, 850115971$repeat:Filamin 24, 850115972$repeat:Filamin 3, 850115973$repeat:Filamin 4, 850115974$repeat:Filamin 5, 850115975$repeat:Filamin 6, 850115976$repeat:Filamin 7, 850115977$repeat:Filamin 8, 850115978$repeat:Filamin 9, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118575$strand, 850118624$turn]
fucosyltransferase 6 (alpha (1,3) fucosyltransferase),INTERPRO[450001336$IPR001503:Glycosyl transferase, family 10]
fucosyltransferase 6 (alpha (1,3) fucosyltransferase),KEGG_PATHWAY[470038784$hsa00601:Glycosphingolipid biosynthesis]
fucosyltransferase 6 (alpha (1,3) fucosyltransferase),OMIM_DISEASE[520001946$Fucosyltransferase-6 deficiency]
fucosyltransferase 6 (alpha (1,3) fucosyltransferase),PIR_SUPERFAMILY[630005650$PIRSF005726:fucosyltransferase]
fucosyltransferase 6 (alpha (1,3) fucosyltransferase),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000616$glycoprotein, 790000619$glycosyltransferase, 790000624$golgi apparatus, 790000691$hexosyltransferase, 790000919$membrane, 790001212$polymorphism, 790001409$Signal-anchor, 790001547$transferase, 790001555$transmembrane]
fucosyltransferase 6 (alpha (1,3) fucosyltransferase),UP_SEQ_FEATURE[850004581$chain:Alpha-(1,3)-fucosyltransferase, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region]
late cornified envelope 1D,INTERPRO[450002847$IPR003267:Small proline-rich]
late cornified envelope 1D,SP_PIR_KEYWORDS[790000356$complete proteome, 790000822$keratinization, 790001212$polymorphism]
late cornified envelope 1D,UP_SEQ_FEATURE[850028023$chain:Late cornified envelope protein 1D, 850102480$compositionally biased region:Cys-rich, 850117295$sequence variant]
matrin 3,BIOCARTA[30000020$h_antisensePathway:RNA polymerase III transcription]
matrin 3,INTERPRO[450000430$IPR000504:RNA recognition motif, RNP-1, 450000591$IPR000690:Zinc finger, C2H2-type matrin, 450003164$IPR003604:Zinc finger, U1-type, 450006475$IPR007087:Zinc finger, C2H2-type, 450011357$IPR012677:Nucleotide-binding, alpha-beta plait, 450014303$IPR015880:Zinc finger, C2H2-like]
matrin 3,SMART[760000323$SM00355:ZnF_C2H2, 760000328$SM00360:RRM, 760000396$SM00451:ZnF_U1]
matrin 3,SP_PIR_KEYWORDS[790000012$acetylation, 790000356$complete proteome, 790000445$direct protein sequencing, 790000937$metal-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001304$repeat, 790001339$rna-binding, 790001648$zinc, 790001651$zinc-finger]
matrin 3,UP_SEQ_FEATURE[850030629$chain:Matrin-3, 850105212$domain:RRM 1, 850105213$domain:RRM 2, 850106258$modified residue, 850117294$sequence conflict, 850117610$short sequence motif:Nuclear localization signal, 850118835$zinc finger region:Matrin-type]
natural cytotoxicity triggering receptor 3,INTERPRO[450003160$IPR003599:Immunoglobulin subtype, 450006486$IPR007110:Immunoglobulin-like, 450011750$IPR013106:Immunoglobulin V-set, 450012396$IPR013783:Immunoglobulin-like fold]
natural cytotoxicity triggering receptor 3,KEGG_PATHWAY[470038868$hsa04650:Natural killer cell mediated cytotoxicity]
natural cytotoxicity triggering receptor 3,OMIM_DISEASE[520002058$Genome-wide association yields new sequence variants at seven loci that associate with measures of obesity, 520003046$Malaria, mild, susceptibility to]
natural cytotoxicity triggering receptor 3,PIR_SUPERFAMILY[630029626$PIRSF038040:Natural cytotoxicity triggering receptor 3]
natural cytotoxicity triggering receptor 3,SMART[760000357$SM00409:IG]
natural cytotoxicity triggering receptor 3,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000264$cell membrane, 790000356$complete proteome, 790000447$disulfide bond, 790000616$glycoprotein, 790000768$Immunoglobulin domain, 790000919$membrane, 790001212$polymorphism, 790001301$receptor, 790001405$signal, 790001555$transmembrane]
natural cytotoxicity triggering receptor 3,UP_SEQ_FEATURE[850033768$chain:Natural cytotoxicity triggering receptor 3, 850102883$disulfide bond, 850104199$domain:Ig-like, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
pleckstrin homology domain containing, family H (with MyTH4 domain) member 3,INTERPRO[450000257$IPR000299:FERM domain, 450000748$IPR000857:Unconventional myosin/plant kinesin-like protein/non-motor protein conserved region MyTH4, 450001635$IPR001849:Pleckstrin homology, 450010818$IPR011993:Pleckstrin homology-type, 450017984$IPR019747:FERM conserved site, 450017985$IPR019748:FERM central domain, 450017986$IPR019749:Band 4.1 domain]
pleckstrin homology domain containing, family H (with MyTH4 domain) member 3,SMART[760000121$SM00139:MyTH4, 760000205$SM00233:PH, 760000266$SM00295:B41]
pleckstrin homology domain containing, family H (with MyTH4 domain) member 3,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism, 790001405$signal]
pleckstrin homology domain containing, family H (with MyTH4 domain) member 3,UP_SEQ_FEATURE[850039569$chain:Pleckstrin homology domain-containing family H member 3, 850102581$compositionally biased region:Poly-Ser, 850103760$domain:FERM, 850104813$domain:MyTH4, 850104979$domain:PH, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant]
poly(rC) binding protein 4,INTERPRO[450003602$IPR004087:K Homology, 450003603$IPR004088:K Homology, type 1, 450016411$IPR018111:K Homology, type 1, subgroup]
poly(rC) binding protein 4,PIR_SUPERFAMILY[630012818$PIRSF016046:PIRSF016046]
poly(rC) binding protein 4,SMART[760000291$SM00322:KH]
poly(rC) binding protein 4,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790000466$dna-binding, 790001212$polymorphism, 790001304$repeat, 790001325$ribonucleoprotein, 790001339$rna-binding]
poly(rC) binding protein 4,UP_SEQ_FEATURE[850039771$chain:Poly(rC)-binding protein 4, 850104521$domain:KH 1, 850104527$domain:KH 2, 850104528$domain:KH 3, 850117295$sequence variant, 850118574$splice variant]
protein kinase, X-linked,INTERPRO[450000618$IPR000719:Protein kinase, core, 450000836$IPR000961:AGC-kinase, C-terminal, 450002035$IPR002290:Serine/threonine protein kinase, 450007563$IPR008271:Serine/threonine protein kinase, active site, 450015769$IPR017441:Protein kinase, ATP binding site, 450015770$IPR017442:Serine/threonine protein kinase-related]
protein kinase, X-linked,KEGG_PATHWAY[470038827$hsa04010:MAPK signaling pathway, 470038829$hsa04020:Calcium signaling pathway, 470038831$hsa04062:Chemokine signaling pathway, 470038835$hsa04114:Oocyte meiosis, 470038843$hsa04210:Apoptosis, 470038845$hsa04270:Vascular smooth muscle contraction, 470038846$hsa04310:Wnt signaling pathway, 470038849$hsa04340:Hedgehog signaling pathway, 470038858$hsa04540:Gap junction, 470038876$hsa04720:Long-term potentiation, 470038879$hsa04740:Olfactory transduction, 470038880$hsa04742:Taste transduction, 470038882$hsa04910:Insulin signaling pathway, 470038883$hsa04912:GnRH signaling pathway, 470038884$hsa04914:Progesterone-mediated oocyte maturation, 470038885$hsa04916:Melanogenesis, 470038895$hsa05020:Prion diseases, 470038896$hsa05110:Vibrio cholerae infection, 470038922$hsa05414:Dilated cardiomyopathy]
protein kinase, X-linked,PIR_SUPERFAMILY[630000671$PIRSF000564:kinase-related transforming protein]
protein kinase, X-linked,SMART[760000115$SM00133:S_TK_X, 760000193$SM00220:S_TKc]
protein kinase, X-linked,SP_PIR_KEYWORDS[790000138$atp-binding, 790000316$chromosomal rearrangement, 790000356$complete proteome, 790000825$kinase, 790001063$nucleotide-binding, 790001212$polymorphism, 790001388$serine/threonine-protein kinase, 790001547$transferase]
protein kinase, X-linked,UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850000242$binding site:ATP, 850059958$chain:Serine/threonine-protein kinase PRKX, 850103028$domain:AGC-kinase C-terminal, 850105086$domain:Protein kinase, 850106263$nucleotide phosphate-binding region:ATP, 850117295$sequence variant]
radial spoke head 4 homolog A (Chlamydomonas),INTERPRO[450006208$IPR006802:Radial spokehead-like protein]
radial spoke head 4 homolog A (Chlamydomonas),OMIM_DISEASE[520001038$Ciliary dyskinesia, primary, 11]
radial spoke head 4 homolog A (Chlamydomonas),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000267$cell projection, 790000321$cilium, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000446$disease mutation, 790001212$polymorphism]
radial spoke head 4 homolog A (Chlamydomonas),UP_SEQ_FEATURE[850056583$chain:Radial spoke head protein 4 homolog A, 850102507$compositionally biased region:Glu-rich, 850117295$sequence variant, 850118574$splice variant]
regulatory factor X-associated ankyrin-containing protein,INTERPRO[450001870$IPR002110:Ankyrin, 450015686$IPR017362:DNA-binding, RFXANK]
regulatory factor X-associated ankyrin-containing protein,KEGG_PATHWAY[470038860$hsa04612:Antigen processing and presentation, 470038919$hsa05340:Primary immunodeficiency]
regulatory factor X-associated ankyrin-containing protein,OMIM_DISEASE[520003277$MHC class II deficiency, complementation group B]
regulatory factor X-associated ankyrin-containing protein,PIR_SUPERFAMILY[630029617$PIRSF038034:DNA-binding_RFXANK]
regulatory factor X-associated ankyrin-containing protein,SMART[760000220$SM00248:ANK]
regulatory factor X-associated ankyrin-containing protein,SP_PIR_KEYWORDS[790000020$activator, 790000053$alternative splicing, 790000086$ank repeat, 790000356$complete proteome, 790000445$direct protein sequencing, 790000446$disease mutation, 790000466$dna-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001360$scid, 790001539$Transcription, 790001543$transcription regulation]
regulatory factor X-associated ankyrin-containing protein,UP_SEQ_FEATURE[850015983$chain:DNA-binding protein RFXANK, 850115632$repeat:ANK 1, 850115644$repeat:ANK 2, 850115654$repeat:ANK 3, 850115655$repeat:ANK 4, 850115656$repeat:ANK 5, 850117295$sequence variant, 850118574$splice variant]
shisa homolog 3 (Xenopus laevis),SP_PIR_KEYWORDS[790000356$complete proteome, 790000428$developmental protein, 790000499$endoplasmic reticulum, 790000919$membrane, 790001212$polymorphism, 790001405$signal, 790001555$transmembrane]
shisa homolog 3 (Xenopus laevis),UP_SEQ_FEATURE[850047668$chain:Protein shisa-3 homolog, 850102580$compositionally biased region:Poly-Pro, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
trafficking protein particle complex 1,INTERPRO[450006602$IPR007233:Sybindin-like protein]
trafficking protein particle complex 1,PIR_SUPERFAMILY[630013750$PIRSF016974:TRAPP I complex, Bet5/Trs23 subunits, 630030652$PIRSF500431:TRAPP I complex, Bet5 subunit]
trafficking protein particle complex 1,SP_PIR_KEYWORDS[790000356$complete proteome, 790000446$disease mutation, 790000499$endoplasmic reticulum, 790000510$er-golgi transport, 790000624$golgi apparatus, 790001558$transport]
trafficking protein particle complex 1,UP_SEQ_FEATURE[850064879$chain:Trafficking protein particle complex subunit 1, 850117295$sequence variant]
versican,INTERPRO[450000128$IPR000152:EGF-type aspartate/asparagine hydroxylation conserved site, 450000373$IPR000436:Sushi/SCR/CCP, 450000461$IPR000538:Link, 450000637$IPR000742:EGF-like, type 3, 450001149$IPR001304:C-type lectin, 450001663$IPR001881:EGF-like calcium-binding, 450002094$IPR002353:Type II antifreeze protein, 450003160$IPR003599:Immunoglobulin subtype, 450005635$IPR006209:EGF, 450005636$IPR006210:EGF-like, 450006486$IPR007110:Immunoglobulin-like, 450011699$IPR013032:EGF-like region, conserved site, 450011750$IPR013106:Immunoglobulin V-set, 450012396$IPR013783:Immunoglobulin-like fold, 450014444$IPR016060:Complement control module, 450014523$IPR016186:C-type lectin-like, 450016397$IPR018097:EGF-like calcium-binding, conserved site, 450016659$IPR018378:C-type lectin, conserved site]
versican,KEGG_PATHWAY[470038855$hsa04514:Cell adhesion molecules (CAMs)]
versican,OMIM_DISEASE[520005065$Wagner syndrome 1]
versican,PIR_SUPERFAMILY[630002392$PIRSF002268:proteoglycan link protein, 630009173$PIRSF010350:chicken chondroitin sulfate proteoglycan PG-M core protein]
versican,SMART[760000024$SM00032:CCP, 760000026$SM00034:CLECT, 760000153$SM00179:EGF_CA, 760000155$SM00181:EGF, 760000357$SM00409:IG, 760000391$SM00445:LINK]
versican,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000211$calcium, 790000252$cataract, 790000356$complete proteome, 790000445$direct protein sequencing, 790000447$disulfide bond, 790000481$egf-like domain, 790000530$extracellular matrix, 790000616$glycoprotein, 790000735$hyaluronic acid, 790000768$Immunoglobulin domain, 790000848$Lectin, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001269$proteoglycan, 790001304$repeat, 790001363$Secreted, 790001405$signal, 790001471$sushi, 790001555$transmembrane]
versican,UP_SEQ_FEATURE[850100205$chain:Versican core protein, 850102883$disulfide bond, 850103184$domain:C-type lectin, 850103597$domain:EGF-like 1, 850103644$domain:EGF-like 2; calcium-binding, 850104407$domain:Ig-like V-type, 850104724$domain:Link 1, 850104725$domain:Link 2, 850105415$domain:Sushi, 850105770$glycosylation site:N-linked (GlcNAc...), 850106258$modified residue, 850111730$region of interest:GAG-alpha (glucosaminoglycan attachment domain), 850111731$region of interest:GAG-beta, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant]
